← Open Payments lookup

VENKATASUBRAMANIAN BASKARARAJAN: Open Payments

NPI 1407052228 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,441 in 81 payments from 11 companies in 2025. Trend: 2023 $794 · 2024 $874 · 2025 $1,441

Food & beverage: $1,441
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.17$284
Janssen Pharmaceuticals, Inc12$212
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$192
ABBVIE INC.12$154
Alkermes, Inc.9$137
Lundbeck LLC6$116
Axsome Therapeutics, Inc.5$100
Vanda Pharmaceuticals Inc.3$83
Otsuka America Pharmaceutical, Inc.3$57
Neurocrine BioSciences, Inc.2$55

Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, Auvelity, FANAPT.

Industry payments across MS — which companies pay providers there.